BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2020
View Archived Issues
Toxicity, infectivity separate issues for prion protein
Read More
Bio-Path begins phase I study of BP-1002 in advanced lymphoid malignancies
Read More
Synthetic lethal approach for some breast, brain cancers
Read More
CuraSen begins phase I study of CST-2032 for neurodegenerative disease
Read More
Stem cell-derived CC exosomes improve MI recovery in pigs
Read More
Vaxess partners with Medigen Vaccine on combined COVID-19 and influenza vaccine
Read More
Synthekine closes series A financing to advance its innovative pipeline
Read More
Proniras receives NIDA grant to pursue development of tezampanel for opioid withdrawal
Read More
Institute of Organic Chemistry and Biochemistry of the ASCR divulges hSTING agonists
Read More
Researchers discloses EFdA prodrugs for HIV infections
Read More
Autobahn Therapeutics synthesizes new TR-beta agonists
Read More
Moderna and Vertex enter new collaboration to develop gene-editing therapies for CF
Read More
FDA approves pilot study of hCT-MSCs therapy to treat COVID-19-related MIS-C
Read More
Eisai presents compounds for cognitive disorders
Read More
New CDK2/cyclin E inhibitors patented by Incyte
Read More
Phase III EMPACTA trial of Actemra in COVID-19-associated pneumonia meets primary endpoint
Read More
BG-P-TAT, novel dual targeting agent with promising efficacy in models of neuroblastoma
Read More
Novel mutation in the PRKCG gene tied to spinocerebellar ataxia 14
Read More
Sorrento cleared by FDA to conduct phase I study of COVI-GUARD for COVID-19
Read More
Animal model shows potential of fluvoxamine for non-motor Parkinson's disease symptoms
Read More
Junshi and Wigen collaborate on four of Wigen's cancer drug candidates
Read More
FDA clears IND for phase I study of MOR-210 in advanced solid tumors
Read More
INT-230-6 studied in combination with Yervoy for advanced cancers in phase II
Read More
New phase II trial investigates fostamatinib for treatment of hospitalized COVID-19 patients
Read More
Elicio collaborates with Moffitt to characterize AMP-CD19 with CAR T cells
Read More
Celltrion cleared in Korea to begin phase II/III study of CT-P59 for COVID-19
Read More
Papyrus and Oxford Biomedica sign research collaboration agreement for CAR-T cell development
Read More
HSG and Prilenia partner on phase III study of pridopidine in Huntington's disease
Read More
NanoViricides nominates NV-CoV-1-R as clinical drug candidate for COVID-19
Read More
Covimro shown to disrupt viral membrane and dislodge S spike proteins
Read More